Early evaluation of liver metastasis using spectral CT to predict outcome in patients with colorectal cancer treated with FOLFOXIRI and bevacizumab.

Shenglin LiLong YuanMengying YueYuan XuSuwei LiuFeng WangXiaoqin LiuFengyan WangJuan DengQiu SunXianwang LiuCaiqiang XueTing LuWenjuan ZhangJunlin Zhou

Published in: Cancer imaging : the official publication of the International Cancer Imaging Society (2023)

Spectral CT IoD can predict the OS and response of patients with CRLM after 2 months of treatment with bevacizumab-containing therapy.

Keyphrases

dual energy
metastatic colorectal cancer
computed tomography
image quality
optical coherence tomography
contrast enhanced
positron emission tomography
magnetic resonance imaging
stem cells
combination therapy
replacement therapy